Goldman Sachs’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Goldman Sachs's RGEN Position: Q2 2026 in Review
Goldman Sachs increased its Repligen (RGEN) stake by 48% in Q2 2026, buying an estimated $38.6M and bringing the position to 965,411 shares worth $132M. The position accounts for 0.01% of the portfolio, ranked #1023.
Goldman Sachs first reported a position in RGEN in Q4 2013 and has held it in 51 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Goldman Sachs held 965,411 shares of Repligen worth $132M as of Q2 2026.
- Goldman Sachs bought 314,064 Repligen shares in Q2 2026, an estimated $38.6M.
- Repligen made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1023 holding.
- Goldman Sachs first reported a position in Repligen in Q4 2013 and has held it in 51 quarters since.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.